Triall joins the Pistoia Alliance

Triall announces that it has joined the Pistoia Alliance, a not-for-profit members’ organization that works to lower barriers to innovation in the Life Sciences and healthcare research and development (R&D) through pre-competitive collaboration. Triall will provide its expertise to help address bottlenecks in clinical research by using the latest open standards in blockchain-enabled technology.

What is the Pistoia Alliance?
The Pistoia Alliance (est. 2008) is a well-established global, not-for-profit members’ organization aimed at lowering barriers to R&D innovation by enabling the development of integrated healthcare solutions. It provides a legal framework, virtual operational model, and professional project management to facilitate member-initiated pre-competitive collaborations. The Pistoia Alliance currently has more than 150 members (including 14 of the top 20 Big Pharma), including leading biopharma companies, technology suppliers, institutes, consultancies, publishers, and start-ups. It allows members to submit new project ideas to their interactive project portfolio platform (IP3) that highlights active projects, supports discussions, and provides updates and status reports. Moreover, the Pistoia Alliance is engaged in a variety of activities (such as annual events, hackathons, and workshops) to identify and support new companies, new science, and new technologies for the benefit of its members.

Why Triall joined the Pistoia Alliance
The Triall Foundation and Pistoia Alliance share a common mission of advancing Life Sciences R&D through novel scientific insights and emerging technologies. By developing blockchain-enabled software solutions for clinical trial professionals, our aim is to promote research data integrity, audibility, system interoperability, and operational excellence. The Pistoia Alliance offers great opportunities for collaboration, and we hope to work together with its members to make clinical trials smarter, safer, and more-efficient.

Triall positions itself as a translational agent, bridging blockchain and document management expertise with profound understanding of clinical R&D. We will support the Pistoia Alliance community in addressing some of the bottlenecks in modern-day clinical trials, applying the latest open standards in blockchain-enabled technology, such as Decentralized Identifiers (DIDs) and Verifiable Credentials. As a technology-focused initiative centered around digital collaboration, we have a strong interest in the AI & MLUX for Life Sciences and FAIR implementation project groups. In addition, we aim to engage with projects that can benefit from blockchain-secured Identity & Access Management (IAM) and auditability solutions. 

“We are very pleased to welcome the Triall Foundation into The Pistoia Alliance, and look forward to working with them to achieve our goal of lowering barriers to innovation in the life science industry. The world of life sciences R&D continues to change rapidly – and sharing, partnering and collaborating will be essential to increased innovation. As our membership continues to grow, our projects and initiatives will be vital in fostering this collaborative mind-set and leading to new breakthroughs,” commented Dr Steve Arlington, President of The Pistoia Alliance.

More information on the Pistoia Alliance can be found at their website.